NY S05150 | 2019-2020 | General Assembly

Status

Spectrum: Partisan Bill (Democrat 5-0)
Status: Introduced on April 11 2019 - 25% progression
Action: 2019-06-20 - RECOMMITTED TO RULES
Pending: Senate Rules Committee
Text: Latest bill text (Amended) [HTML]

Summary

Provides that with the first opioid prescription of each year for use in a setting other than a general hospital or nursing home under article twenty-eight of this chapter or facility under article thirty-one of the mental hygiene law, or when a practitioner is prescribing a controlled substance to a patient under the care of hospice, the prescriber shall prescribe an opioid antagonist when any of the following risk factors are present: a history of substance abuse disorder; high dose or cumulative prescriptions that result in over 50 morphine milligram equivalents per day; concurrent use of opioids and benzodiazepine or nonbenzodiazepine sedative hypnotics.

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Provides that with the first opioid prescription of each year for use in a setting other than a general hospital or nursing home under article twenty-eight of this chapter or facility under article thirty-one of the mental hygiene law, or when a practitioner is prescribing a controlled substance to a patient under the care of hospice, the prescriber shall prescribe an opioid antagonist when any of the following risk factors are present: a history of substance abuse disorder; high dose or cumulative prescriptions that result in over 50 morphine milligram equivalents per day; concurrent use of opioids and benzodiazepine or nonbenzodiazepine sedative hypnotics.

Sponsors


History

DateChamberAction
2019-06-20SenateRECOMMITTED TO RULES
2019-06-19SenateORDERED TO THIRD READING CAL.1773
2019-06-19SenateCOMMITTEE DISCHARGED AND COMMITTED TO RULES
2019-06-13SenatePRINT NUMBER 5150B
2019-06-13SenateAMEND AND RECOMMIT TO HEALTH
2019-05-22SenatePRINT NUMBER 5150A
2019-05-22SenateAMEND (T) AND RECOMMIT TO HEALTH
2019-04-11SenateREFERRED TO HEALTH

Same As/Similar To

A05603 (Same As) 2019-06-13 - print number 5603b

New York State Sources


Bill Comments

feedback